+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06907862

Comparing High and Low Ultra-Processed Soy Protein Foods in a Digital Diet Program to Improve Blood Pressure and Heart Health in Adults with Hypertension and Obesity

Led by University of Toronto · Updated on 2026-05-04

300

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effects of a digital dietary intervention enhanced with vegetables, fruit, and soy protein foods on blood pressure and cardiometabolic health in adults with hypertension and obesity, half of whom have type 2 diabetes. This randomized, controlled study includes three groups to compare high ultra-processed soy protein foods, low ultra-processed soy protein foods, and standard care. The study aims to assess if high ultra-processed soy foods are similar to low ultra-processed soy foods in their impact on blood pressure and cardiometabolic risk factors, and whether the digital intervention improves these health outcomes compared to usual care over 12 weeks. Participants will be assigned to one of three groups an active treatment group receiving a high ultra-processed soy-containing digital dietary intervention, a reference treatment group receiving a low ultra-processed soy-containing digital dietary intervention, or a control group receiving standard care from their doctor. Both treatment groups will consume at least four servings of soy products daily and incorporate a provided blend of dehydrated vegetables and fruit. The digital intervention includes a health app, weekly text support, a seven-session online behavior change program, and a virtual focus group at week 4. Participants will attend in-person clinic visits at baseline, week 8, and week 12, arriving fasted for blood pressure and body measurements, blood sampling, and review of dietary records and questionnaires. They will also provide fecal and urine samples at baseline and week 12. A phone call at week 1 will check on adherence and answer questions. The main outcome measured is systolic blood pressure over 12 weeks, with secondary outcomes including cholesterol, body weight, diastolic blood pressure, blood lipids, glycemic control, insulin, inflammation, and body composition. Participants are asked to maintain their usual lifestyle and physical activity during the study.

CONDITIONS

Brief Title

The SWITCH (Substitution of High With Low Ultra-processed Soy Protein Foods In a Guideline-based Diet inTervention for Cardiometabolic Health) Trial

Research Team

L

Laura Chiavaroli, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here